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Aim: Research identifies a need for expanded therapeutic options for people with mild-to-
moderate depression and anxiety disorders treated within the UK National Health Service 
(NHS). We aimed to examine potential benefits of a Sudarshan Kriya Yoga (SKY) based 
breath intervention delivered in this context. 
Background: SKY is a structured programme derived from yoga in which participants are 
taught relaxation and stress-management techniques including body postures, breathing 
exercises and cognitive-behavioural procedures. Previous research has demonstrated benefits 
for patients with clinical and non-clinical depression and anxiety. However, SKY has not yet 
been evaluated as a therapeutic option for patients accessing NHS primary care mental health 
services. 
Methods: We evaluated an existing programme available to NHS patients in South East 
England. The intervention is community-based and GHOLYHUHGYLD IRXUZHHNO\ µVWUHVVEXVWHU
VHVVLRQV¶-hour duration), one weekend intensive workshop (2.5 days) and four weekly (90 
minute) follow-up sessions. Analyses were conducted on existing data (measures of 
depression [PHQ9] and anxiety [GAD7]) collected as part of routine care, at the start of the 
programme and three follow-up assessments.  
Findings: Baseline data were available for 991 participants, of which 557 (56.2%) attended at 
least 3 weekly workshops, 216 (21.8%) attended the weekend workshop and 169 (17.1%) 
completed the programme. Statistically significant (p<.05) improvements in depression and 
anxiety were observed in all three outcome assessments. Clinically meaningful change was 
observed for 74.6% of participants completing the programme. Findings indicate that SKY 
has the potential to benefit patient outcomes and could be offered more widely as a 
therapeutic option. We UHFRPPHQG IXUWKHU UHVHDUFK WR H[SORUH SDWLHQWV¶ H[SHULHQFHV RI WKH
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programme, determine the number of sessions necessary for improvement/ recovery, define 
the population most likely to respond and examine potential cost savings (e.g. reductions in 







A systematic review and meta-analysis including 174 surveys across 63 countries revealed 
that almost one in five respondents met criteria for common mental disorder during the 
previous 12 months and 29.2% met lifetime prevalence.  Anxiety and mood disorders had the 
highest 12-month prevalence rates; affecting 1 in 15 and 1 in 20 people annually (Steel et al., 
2014). Findings from the Global Burden of Disease Study (2010) indicate that depression and 
anxiety are the leading cause of adult disability worldwide (Whiteford et al., 2013). The 
World Health Organisation reports that the burden of mental health disorders is continuing to 
grow, with significant impacts on health and wellbeing, as well as major social and economic 
consequences (WHO, 2017). 
 
Consistent with the global picture, statistics for the UK indicate that around one in four adults 
will experience mental ill health at some point in their lives and at least one in six has a 
mental health problem at any given time. The total cost of mental health to the economy in 
England has been estimated at £105 billion, with treatment costs expected to double over the 
next twenty years. Personal and societal costs are also significant; people with mental health 
problems are more likely to experience unemployment and homelessness and to live in areas 
of high social deprivation and they are more likely to have poor physical health, which is due 
in part to higher rates of risk behaviours, such as smoking, poor diet, physical inactivity, 
alcohol and substance misuse (Department of Health, 2011).  
 
The Improving Access to Psychological Therapies (IAPT) programme is a national 
programme developed to improve access to evidence-based treatments for depression and 
anxiety disorders within the UK National Health Service (NHS). IAPT services are primary 
care mental health services, which offer psychological therapies recommended by the 
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National Institute for Health and Clinical Excellence (NICE) within a stepped care 
framework. Following an assessment of psychological needs (step 1), patients with moderate-
to-severe depression and some anxiety disorders (e.g. post-traumatic stress disorder) are 
referred directly WR VWHS  µKLJK LQWHQVLW\¶ +, LQWHUYHQWLRQV RQH-to-one psychological 
therapies), while those with mild-to-moderate anxiety and depression are first offered step 2 
µORZLQWHQVLW\¶/,LQWHUYHQWLRQVLQFOXGLQJJXLGHGVHOI-help, exercise and psychoeducation) 
(Clark, 2011). LI interventions have a number of features which differentiate them from HI 
treatments including lower complexity, reduced contact time and the use of novel forms of 
delivery (e.g. telephone sessions, group treatment, computerised Cognitive Behavioural 
Therapy and provision of self-KHOSPDWHULDO3DWLHQWVFDQEHµVWHSSHGXS¶WR+,WKHUDSLHVLI
symptoms do not improve, or there is evidence of increasing need/risk (Ali et al., 2014; 
Bennett-Levy et al., 2010; Rodgers et al., 2012). For full guidance on assessment and 
pathways to care, see NICE (2011). 
 
The IAPT programme has been successful in improving access to psychological therapies - 
more than a million people accessed IAPT services in the first three years, of which 680,000 
completed a course of treatment. Of these, around two thirds showed reliable improvement in 
symptoms and 41% moved to recovery (Department of Health, 2012).  Recent data indicate 
that 39.7% complete treatment, with 65.7% of completers showing reliable improvement and 
50.4% moving to recovery (Health and Social Care Information Centre, 2017). However, 
limitations have also been highlighted. For example, research indicates that only a small 
proportion of people with depression and anxiety disorders meeting criteria for psychological 
therapies participate in stepped care programmes when offered. Attrition is a problem and 
occurs more commonly in the first step, suggesting that failure to respond to LI interventions 
may discourage further engagement. Researchers have therefore advocated expanded patient 
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choice, including access to different interventions within steps or options regarding intensity 
of intervention across steps (e.g. timing, frequency and style of treatment sessions) (Firth et 
al., 2014; Kay-Lambkin et al., 2010; Seekles et al., 2011). 
 
Sudarshan Kriya Yoga (SKY) is a comprehensive programme derived from yoga, which has 
been delivered by certified instructors to millions of people in 152 countries worldwide. 
Participants are taught practical relaxation and stress-management techniques including body 
postures, breathing exercises and cognitive-behavioural procedures. Previous research 
indicates a range of benefits including improvements in measures of stress, sleep quality, 
wellbeing, cardiovascular, endocrine and immune function (Agte et al., 2011; Janakiramaiah 
et al., 1998; Kjellgren et al., 2007; Subramanian et al., 2012; Toschi-Dias et al., 2017; 
Vedamurthachar et al., 2006). Several studies have demonstrated improvements in clinical 
and non-clinical depression and anxiety (Doria et al., 2015; Janakiramaiah et al., 2000; 
Katzman et al., 2012; Seppala et al., 2014; Toschi-Dias et al., 2017). The potential benefits of 
offering a SKY based intervention programme as a treatment option within the IAPT 




The aim of the current study was to examine the potential benefits of a SKY based 








We conducted an evaluation of an intervention programme available to NHS patients with 
mild-to-moderate depression and anxiety disorders in South East England. Patients access the 
programme via the following routes: 
 
1. IAPT services refer patients if they are assessed as suitable for low intensity (LI) 
interventions. 
2. GPs refer patients with low-level mental health needs that require support. 
3. The programme is free to attend and publicised via a website and information leaflets, so 
people can also self-refer. There has also been some media coverage and some patients hear 
of the programme through friends who have attended. They can contact the service directly 
for enquiries and bookings. 
 
Patients referred to/contacting the service complete a questionnaire before attending in which 
they provide details of their current health and past medical history. They are accepted onto 
the programme provided they do not meet the following exclusion criteria: age < 16 years, 
pregnant, suicide risk, psychosis, drug or alcohol addiction, taking lithium / other 
tranquilizing medication used to manage severe mental illness 
 
Data analysis was conducted on existing data collected as part of routine care and stored in 
accordance with the Data Protection Act. Data for patients entering the programme between 4 
January 2013 and 2 July 2017 were included in the analyses. Analyses were conducted on 







Manage Your Mind (MYM) is a community programme teaching stress-management and 
FRSLQJ VNLOOV YLD IRXU ZHHNO\ µVWUHVV EXVWHU VHVVLRQV¶  KRXU GXUDWLRQ RQH ZHHNHQG
intensive workshop (2.5 days) and four weekly (90 minute) follow-up sessions. Workshops 
are facilitated by a certified SKY instructor. Stress buster sessions cover: basic breathing 
techniques to eliminate stress and tension; guided meditations and processes that calm the 
mind; knowledge of impacts of lifestyle on health; skills for handling negative emotions and 
everyday situations and practical advice on improving work and interpersonal relationships. 
These components are reinforced at the weekend workshop, in which participants are taught 
SKY techniques (see Figure 1), together with cognitive coping and stressor evaluation 
strategies. Follow-up sessions provide an opportunity for participants to practice techniques 
with feedback and support from the instructor. Although it is recommended that participants 
attend the whole programme, this is not a requirement and participants may attend as many 
sessions as they wish. 
 




The nine-item version of the Patient Health Questionnaire (PHQ-9; Spitzer et al., 1994) is 
used to monitor change in depression symptoms over time, with severity index as follows: 0-
4 (no depression), 5-9 (mild), 10-14 (moderate), 15-19 (moderately severe), 20-27 (severe). 
Scores of 10 or above are considered to be clinically significant, which is referred to as 
³FDVHQHVV´$VHYHQ-item measure of Generalised Anxiety Disorder (GAD-7; Spitzer et al., 
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2006) is used to measure severity of anxiety symptoms, with index scores as follows: 0-4 (no 
anxiety), 5-9 (mild), 10-14 (moderate) and 15-21 (severe). Patients scoring 8 or above are 




There was evidence of skewness and non-normality in the distribution of both outcome 
variables GAD-7 and PHQ-9, consequently non-parametric tests were used to analyse the 
data. GAD-7 and PHQ-9 were analysed using an intention to treat analysis and Kruskal-
Wallis one way analysis of variance to assess changes from baseline. Last observation carry 
forward (LOCF) methods were used to account for missing data in the intention to treat (ITT) 
analysis.  Sensitivity ITT analysis was conducted using baseline observation carry forward 
(BOCF) and a per protocol analysis of participants with complete data was also performed. A 
response bias assessment of demographic data for completers and non-completers was 
conducted and demographic data summarised.   
 
The number of participants showing reliable improvement/ recovery following treatment was 
calculated following Health and Social Care Information Centre (2014) guidance: reliable 
improvement requires that any improvement in scores for depression or anxiety between pre 
and post treatment exceeds the measurement error of the scales (4 or more points for GAD-7 
or 6 or more points for PHQ-9) and there is no evidence of reliable deterioration (increase in 
scores exceeding the measurement error) on either GAD-7 or PHQ-9. An individual is 
defined as a case if scores are above the clinical threshold for depression and/or anxiety pre-
treatment. Movement to recovery requires that scores for an individual with caseness must be 
below the caseness threshold on both measures at the end of treatment (GAD-7 less than 8 
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points and PHQ-9 less than 10 points). Reliable recovery requires that an individual shows 
reliable improvement and movement to recovery. To determine whether intervention effects 
differed according to demographic characteristics, analyses were repeated for males and 
females separately. Subgroup analyses were also conducted for participants aged 18-35 years, 
36 to 64 years and those aged over 65; these age groupings are consistent with those used for 
reporting IAPT data. Additional subgroup analyses were conducted for participants taking, or 




Baseline data were available for 991 participants, of these 254 were male (25.6%) and 737 
were female (74.4%). The age of participants ranged from 14 to 80 years and the mean age 
was 46 years (standard deviation 14.3 years). Pre-treatment mean scores for GAD-7 and 
PHQ-9 were 10.3 and 10.1 respectively. Scores ranged the full breadth of the scales from 0-
27 for PHQ-9 and 0-21 for GAD-7. At baseline 54% of participants had mild or moderate 
depression as defined by PHQ-9, and 25% of participants had moderately severe or severe 
depression. Similarly, 59% of participants had mild or moderate anxiety at baseline and 24% 
had severe anxiety. Referral data indicated that 689 participants (70.4%) accessed the 
programme via self-referral, while 179 (18.1%) were referred by a GP and 114 (11.5%) were 
referred by a counsellor or health professional. There were no obvious differences between 
these three groups in terms of baseline characteristics. Medication data indicated that 206 
participants (20.8%) were taking medications for depression and/or anxiety, while 785 
(79.2%) were not. In total 169 participants (17.1%) had complete data at all assessment visits. 
The number of participants who completed and withdrew from each stage of the programme 








Summaries of baseline data were compared between completers and non-completers. Table 1 
shows summary statistics for age and baseline scores of GAD-7 and PHQ-9; these were 
similar for completers and non-completers. 
 
Insert Table 1 about here. 
 
Summary statistics based on the intention to treat LOCF dataset are presented in Table 2 and 
Figure 3 below. The median and mean values show a decrease from assessment 1 (baseline) 
in GAD-7 and PHQ-9 at assessments 2, 3 and 4. By the final assessment, only 17% of 
participants had scores in the moderately severe/severe depression range and only 16% in the 
severe anxiety range. Almost twice as many participants had scores less than 5 at the final 
assessment compared to pre-treatment, indicating they were no longer experiencing 
depression or anxiety.     
 
Insert Table 2 and Figure 3 about here. 
 
An intention to treat nonparametric analysis of GAD-7 and PHQ-9 revealed statistically 
significant differences over time, and pairwise comparisons of baseline data with post-
intervention data at assessments 2, 3 and 4 were all statistically significant (P<0.001) 
providing evidence of statistically significant decreases from baseline at all assessments. At 
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the final assessment median anxiety scores were significantly reduced by 30% (p<0.001) and 
median depression scores were significantly reduced by 22% (P< 0.001). The median change 
from baseline was zero at all post-intervention assessments for GAD-7 and PHQ-9, indicating 
that for at least 50% of participants, anxiety and depression scores remained the same or 
increased following treatment; this suggests the intervention may not have benefit for all 
participants.  
 
Summary statistics based on the per protocol dataset are presented in Table 3 and Figure 4 
below. Inspection of mean and median values indicates a large decrease in both GAD-7 and 
PHQ-9 at assessments 2, 3 and 4, which is most marked at assessment 4.     
 
Insert Table 3 and Figure 4 about here. 
 
A per protocol nonparametric analysis of GAD-7 and PHQ-9 revealed statistically significant 
differences over time, and pairwise comparisons of baseline data with post-intervention data 
at assessments 2, 3 and 4 were all statistically significant (P<0.001) providing evidence of 
statistically significant decreases from baseline at all assessments. At the final assessment, 
median anxiety scores for those who completed the programme were significantly reduced by 
80% (p<0.001) and median depression scores were significantly reduced by 78% (P< 0.001).   
 
To assess clinical significance, the IAPT criteria were used to determine the proportion of 
SDWLHQWVZLWKµcaseness¶DW$VVHVVPHQWshowing statistically reliable improvement, and the 
number of participants showing movement to recovery and reliable recovery. The results 
from this analysis are summarised in Table 4. At baseline 74% of completers had scores 
above the caseness threshold, this is lower than the most recent IAPT figures (93.5%) 
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indicating that participants in this evaluation have lower severity at baseline than the IAPT 
referral population. The ITT dataset shows 32.4% of participants with reliable improvement, 
23.3% moving to recovery and 22.0% with reliable recovery. Much higher figures were 
observed for the subset of participants who completed the programme; reliable improvement, 
movement to recovery and reliable recovery more than doubled in this group compared to the 
ITT analysis including all participants.      
 
Insert Table 4 about here. 
 
All significant differences remained when data were analysed separately for males and 
females, for those taking, or not taking medications for depression and anxiety and by age 
group (18-35 years, 36 to 64 years and over 65 years), indicating that intervention effects do 
QRWGLIIHUDFFRUGLQJWRSDUWLFLSDQWV¶DJH, gender, or concurrent medication. There were higher 
baseline depression scores for female participants who completed the MYM programme 
compared to male participants who completed the programme. Those taking medications for 
depression and anxiety had higher baseline levels of depression and anxiety and showed 
larger change from baseline to follow-up than those not taking medications. However, the 
proportionate change was similar across the two groups. The subgroup analysis by age group 
suggested that participants aged between 18 and 35 years were less likely to complete the 
programme compared to the other groups; the completion rate for this group was 9.4% 







Improving uptake of treatment programmes for mild-to-moderate depression and anxiety 
disorders is likely to benefit primary care in a number of ways. For example, teaching 
patients practical techniques for managing their own wellbeing has the potential to reduce 
escalation of low-level mental health problems and avoid the need for (more costly) higher 
intensity interventions, as well as reducing the need for antidepressant medication. Improved 
mental wellbeing may also benefit physical health and reduce demand on health services. We 
aimed to evaluate potential benefits of adding a SKY-based breathing intervention to the 
range of treatments available for patients with mild-to-moderate depression and anxiety 
disorders. 
 
Findings of this preliminary evaluation are encouraging - the course was attended by males 
and females, ranging in age from 14 to 80 years; the majority of participants attended at least 
three weekly sessions and significant improvements in depression and anxiety were observed 
at the first follow-up. Differences remained statistically significant at the second and third 
follow-up. Around two thirds of participants completing the programme moved to recovery, 
with three quarters showing reliable improvement at the final follow-up. Statistically 
significant differences remained when data were analysed using the last observation carried 
forward method for handling missing values. Using this method, clinically significant 
improvement was observed for almost a third of participants. Statistically significant 
differences also remained when data were analysed separately for males and females, for 
younger and older adults and for those taking, or not taking medications for depression and 
anxiety. 
 
Taken together findings suggest that the MYM programme is an effective intervention for 
improving symptoms of mild-to-moderate depression and anxiety in patients meeting criteria 
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for IAPT low intensity treatments and that the intervention is suitable for males and females 
with a wide range of ages. This type of programme may therefore provide a valuable addition 




The study has a number of limitations. First, we do not know why participants chose to 
access the MYM programme, as opposed to other therapies offered as part of the IAPT 
programme. It is possible that patients could have accessed other treatments alongside the 
MYM programme, and/or that participants selected this programme because they had already 
tried other treatment options; however we did not have access to this data, so could not 
consider the effects of previous/concurrent therapies, or explore the reasons underlying 
uptake of the MYM programme. Without information on previous/concurrent therapies (apart 
from depression and anxiety medications), it is difficult to compare rates of improvement and 
recovery with other treatment options. The lack of a control group is a further limiting factor. 
Hence, it will be important to follow-up this preliminary evaluation with research adopting 
more rigorous designs, such as randomised controlled trials. 
 
The MYM programme is for people with mild to moderate severity; however baseline data 
show that 25% of participants had moderately severe or severe depression and 23% had 
severe anxiety. In addition only 72.3% of participants had scores above the caseness 
threshold at baseline. The distribution of participants in this evaluation is less concentrated in 
the mild to moderate severity group compared to the IAPT referral population. This also 





It is also evident that the vast majority of patients entering the programme were female ± this 
is not unusual in studies of Sudarshan Kriya Yoga and is at least partly attributable to the 
increased prevalence of depression and anxiety disorders in females (e.g. Doria et al., 2015). 
However, it would be useful to know more about the reasons for increased uptake among 
female patients. Our data indicate that intervention effects do not differ by gender; hence, if 
males do access the programme, they are just as likely to benefit as females. Future research 
could explore acceptability of SKY based interventions in males and identify factors which 
could be targeted to increase uptake of this type of programme. It would also be useful to 
further investigate gender differences in baseline depression scores among SKY participants. 
 
A further limitation of the current study is the high volume of missing data resulting from 
non-completion of the programme. Although the majority of participants attended at least 
three weekly sessions, a substantial proportion (43.8%) dropped out before the first follow-up 
and less than a quarter completed the weekend workshop; further attrition was evident at the 
final follow-up. As noted previously, participants are not required to attend the entire 
programme and are permitted to attend as many sessions as they wish. However, missing data 
at follow-up raises challenges for evaluation: the per protocol dataset represents only 17.1% 
of participants and may be biased as a result, while the intention to treat LOCF dataset is 
saturated with estimated values. Both analyses should therefore be interpreted with caution. 
The completion rate (17.1%) is low compared to recent IAPT data (39.4%), however it may 
not be necessary to complete all of the MYM programme to have benefit.  Further research is 
warranted to investigate reasons for non-attendance/ withdrawal and to determine whether a 
minimum number of sessions is necessary for patient benefit. Potential cost savings (e.g. 
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reductions in anti-depressant prescribing/ referrals to secondary care mental health services) 
could also be examined. 
 
To advance understanding of the potential benefits of SKY as a treatment option for patients 





This study is the first to examine potential benefits of a SKY based breath intervention for 
NHS patients with mild-to-moderate depression and anxiety disorders. Data for patients 
completing treatment provide evidence of statistically and clinically significant improvement. 
While these preliminary findings are encouraging, further research is needed to explore 
SDWLHQWV¶ H[SHULHQFH RI WKH SURJUDPPH DQd reasons for uptake/withdrawal. It will also be 
important to determine the number of sessions necessary for improvement/ recovery, define 
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Figure 1. SKY Techniques 
The practice of Sudarshan Kriya Yoga involves the use of three breathing techniques: Three Stage 
hũũĂǇŝ  ? ?ǀŝĐƚŽƌǇ ďƌĞĂƚŚ ? ? ? Ă ƐůŽǁ ĚĞĞƉ ďƌĞĂƚŚŝŶŐ ƚĞĐŚŶŝƋƵĞ ǁŝƚŚ Ă ƐƉĞĐŝĨŝĐ ƌĂƚŝŽ ŽĨ ŝŶŚĂůĂtion, 
exhalation and breath holds; ŚĂƐƚƌŝŬĂ  ? ?ďĞůůŽǁƐ ďƌĞĂƚŚ ? ? ? ŝŶǀŽůǀŝŶŐ ŽŶĞ ŵŝŶƵƚĞ ƌŽƵŶĚƐ ŽĨ ĨĂƐƚĞƌ
more vigorous breath, followed by a few minutes of normal breathing; Sudarshan Kriya  ? ?ŚĞĂůŝŶŐ
ďƌĞĂƚŚ ? ? ?an advanced cyclical breathing exercise of slow, medium, and fast rates in succession. 
These practices are done in a sitting posture with eyes closed; specific arm positions/movements are 
used to enhance inhalation, exhalation and breath-holds. Daily SKY practice takes around 10 
minutes. SKY instruction involves longer group sessions, lasting approximately thirty minutes. 
The Manage Your Mind programme provides SKY instruction and practice as part of the intensive 
ǁĞĞŬĞŶĚǁŽƌŬƐŚŽƉ ?sŝĐƚŽƌǇďƌĞĂƚŚĂŶĚďĞůůŽǁƐďƌĞĂƚŚĂƌĞĂůƐŽƚĂƵŐŚƚĂƐƉĂƌƚŽĨƚŚĞǁĞĞŬůǇ ?stress 
ďƵƐƚĞƌƐĞƐƐŝŽŶƐ ? ? 
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Assessed at Baseline (n=991) 
Assessment 2 
Completed 3 weekly sessions (n=557) 
Did not complete 3 weekly sessions (n=434)  
 
Assessment 3 
Completed weekend workshop (n=216) 
Did not complete weekend workshop (n=775)  
 
Assessment 4 
Completed all assessments (n=169) 




Figure 3. Box and Whisker Plot of GAD-7 Scores 
 
Note: The boxes represent the inter-quartile range and are intersected at their median point. 
The whiskers extend to the most extreme point within 1.5 times of the inter-quartile range. 













 Figure 4. Box and Whisker Plot of PHQ-9 Scores 
 
Note: The boxes represent the inter-quartile range and are intersected at their median point. 
The whiskers extend to the most extreme point within 1.5 times of the inter-quartile range. 






Table 1. Demographic and Baseline Data for Completers and Non-Completers 
 Statistic Completers Non-completers 
Females % 79.3 73.4 
Age Mean 48.3 45.0 
SD 12.0 14.7 
Median 48 45 
GAD-7 Mean 10.14 10.33 
SD 5.21 5.39 
Median 10 10 
PHQ-9 Mean 9.53 10.27 
SD 5.69 6.35 








Table 2. Intention to Treat Analysis - Summary Statistics (N=991) 
Outcome Statistic Baseline Assessment 2 Assessment 3 Assessment 4 
GAD-7  
 
Mean 10.30 8.51 7.90 7.81 
SD 5.36 5.45 5.63 5.69 
Median 10 8 7 7 
Interquartile 
range 
8 9 9 9 
PHQ-9 
 
Mean 10.14 8.41 7.98 7.83 
SD 6.24 6.20 6.29 6.36 
Median 9 7 7 7 
Interquartile 
range 




Mean 0 -1.79 -2.40 -2.49 
SD 0 3.79 4.31 4.32 
Median 0 0 0 0 
Interquartile 
range 




Mean 0 -1.73 -2.16 -2.31 
SD 0 3.86 4.38 4.36 
Median 0 0 0 0 
Interquartile 
range 






Table 3. Per Protocol Analysis ± Summary Statistics (N=169) 
 
Outcome Statistic Baseline Assessment 2 Assessment 3 Assessment 4 
GAD-7  
 
Mean 10.14 6.46 3.99 3.47 
SD 5.21 4.66 3.89 3.81 
Median 10 6 3 2 
Interquartile 
range 
8 6 5 4 
PHQ-9 
 
Mean 9.53 6.14 4.24 3.36 
SD 5.69 4.98 4.17 3.90 
Median 9 5 3 2 
Interquartile 
range 




Mean 0 -3.68 -6.14 -6.67 
SD 0 5.17 5.50 5.17 
Median 0 -3 -6 -7 
Interquartile 
range 




Mean 0 -3.38 -5.28 -6.17 
SD 0 5.06 5.96 5.31 
Median 0 -3 -4 -6 
Interquartile 
range 






Table 4. Clinical Significance Based on IAPT Criteria 
Clinical outcome Per protocol 
Analysis 
Intention to treat 
Analysis 
Proportion at or above 
caseness at baseline 
74.0% 72.1% 
Proportion showing reliable 
improvement at Assessment 
4 
74.6% 32.4% 
Proportion moving to 
recovery  at assessment 4 
58.6% 23.3% 
Proportion showing reliable 
recovery at Assessment 4 
56.2% 22.0% 
 
 
 
